Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 9,693 | 63,745 | 17,399 | 14,809 | 8,520 |
| Gross Profit | 9,693 | 63,745 | 17,399 | 14,809 | 8,520 |
| Operating Expenses | 58,152 | 67,090 | 85,913 | 80,067 | 76,439 |
| Operating Income | -48,459 | -3,345 | -68,514 | -65,258 | -67,919 |
| Other Income | -8,398 | -8,172 | -7,454 | -4,830 | 19,132 |
| Pre-tax Income | -56,857 | -11,517 | -75,968 | -70,088 | -48,787 |
| Income Tax | N/A | -18 | N/A | 2,355 | N/A |
| Net Income Continuous | -56,857 | -11,499 | -75,968 | -72,443 | -48,787 |
| Net Income | $-56,857 | $-11,499 | $-75,968 | $-72,443 | $-48,787 |
| EPS Basic Total Ops | -6.70 | -1.40 | -9.10 | -8.30 | -5.90 |
| EPS Basic Continuous Ops | -6.70 | -1.36 | -9.14 | -8.28 | -5.95 |
| EPS Diluted Total Ops | -6.70 | -1.40 | -9.10 | -8.30 | -5.90 |
| EPS Diluted Continuous Ops | -6.70 | -1.36 | -9.14 | -8.28 | -5.95 |
| EPS Diluted Before Non-Recurring Items | -6.70 | -1.40 | -9.10 | -8.90 | -5.90 |
| EBITDA(a) | $-47,314 | $-2,478 | $-67,730 | $-64,929 | $-68,817 |